Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals
Obesity is the dominant cause of insulin resistance. In adult humans it is characterised by a combination of adipocyte hypertrophy and, to a lesser extent, adipocyte hyperplasia. As hypertrophic adipocytes secrete more leptin and less adiponectin, the plasma leptin:adiponectin ratio (LAR) has been proposed as a potentially useful measure of insulin resistance and vascular risk. We sought to assess the usefulness of the LAR as a measure of insulin resistance in non-diabetic white adults.
Leptin and adiponectin levels were measured in 2,097 non-diabetic individuals from the Ely and European Group for the Study of Insulin Resistance (EGIR) Relationship between Insulin Sensitivity and Cardiovascular Risk (RISC) study cohorts. LAR was compared with fasting insulin and HOMA-derived insulin sensitivity (HOMA-S) in all individuals and with the insulin sensitivity index (M/I) from hyperinsulinaemic–euglycaemic clamp studies in 1,226 EGIR RISC participants.
The LAR was highly correlated with HOMA-S in men (r = −0.58, p = 4.5 × 10−33 and r = −0.65, p = 1.1 × 10−66 within the Ely and EGIR RISC study cohorts, respectively) and in women (r = −0.51, p = 2.8 × 10−36 and r = −0.61, p = 2.5 × 10−73). The LAR was also strongly correlated with the clamp M/I value (r = −0.52, p = 4.5 × 10−38 and r = −0.47, p = 6.6 × 10−40 in men and women, respectively), similar to correlations between HOMA-S and the M/I value.
The leptin:adiponectin ratio is a useful measure of insulin resistance in non-diabetic white adults. These data highlight the central role of adipocyte dysfunction in the pathogenesis of insulin resistance. Given that variations between fasting and postprandial leptin and adiponectin levels tend to be small, the leptin to adiponectin ratio might also have potential value in assessing insulin sensitivity in the non-fasted state.
- Badman MK, Flier JS (2007) The adipocyte as an active participant in energy balance and metabolism. Gastroenterology 132:2103–2115 CrossRef
- Satoh N, Naruse M, Usui T et al (2004) Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients. Diabetes Care 27:2488–2490 CrossRef
- Zhuo Q, Wang Z, Fu P et al (2009) Comparison of adiponectin, leptin and leptin to adiponectin ratio as diagnostic marker for metabolic syndrome in older adults of Chinese major cities. Diabetes Res Clin Pract 84:27–33 CrossRef
- Frystyk J, Tarnow L, Hansen TK, Parving HH, Flyvbjerg A (2005) Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications. Diabetologia 48:1911–1918 CrossRef
- Semple RK, Soos MA, Luan J et al (2006) Elevated plasma adiponectin in humans with genetically defective insulin receptors. J Clin Endocrinol Metab 91:3219–3223 CrossRef
- Wallace TM, Matthews DR (2002) The assessment of insulin resistance in man. Diabet Med 19:527–534 CrossRef
- Williams DR, Wareham NJ, Brown DC et al (1995) Undiagnosed glucose intolerance in the community: the Isle of Ely Diabetes Project. Diabet Med 12:30–35 CrossRef
- Hills SA, Balkau B, Coppack SW et al (2004) The EGIR-RISC STUDY (The European Group for the Study of Insulin Resistance: Relationship between Insulin Sensitivity and Cardiovascular Disease Risk): I. Methodology and objectives. Diabetologia 47:566–570 CrossRef
- Gray SL, Vidal-Puig AJ (2007) Adipose tissue expandability in the maintenance of metabolic homeostasis. Nutr Rev 65:S7–12 CrossRef
- Cinti S, Mitchell G, Barbatelli G et al (2005) Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 46:2347–2355 CrossRef
- Hung YJ, Chu NF, Wang SC et al (2006) Correlation of plasma leptin and adiponectin with insulin sensitivity and beta-cell function in children—the Taipei Children Heart Study. Int J Clin Pract 60:1582–1587 CrossRef
- Oda N, Imamura S, Fujita T et al (2008) The ratio of leptin to adiponectin can be used as an index of insulin resistance. Metab Clin Exper 57:268–273
- Semple RK, Halberg NH, Burling K et al (2007) Paradoxical elevation of high-molecular weight adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies. Diabetes 56:1712–1717 CrossRef
- Considine RV, Premkumar A, Reynolds JC, Sebring NG, Ricks M, Sumner AE (2008) Adiponectin and leptin in African Americans. Obesity (Silver Spring) 16:428–434 CrossRef
- Gavrila A, Peng CK, Chan JL, Mietus JE, Goldberger AL, Mantzoros CS (2003) Diurnal and ultradian dynamics of serum adiponectin in healthy men: comparison with leptin, circulating soluble leptin receptor, and cortisol patterns. J Clin Endocrinol Metabol 88:2838–2843 CrossRef
- Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
Volume 52, Issue 11 , pp 2345-2349
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Insulin resistance
- Industry Sectors
- Author Affiliations
- 1. MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge, UK
- 2. Metabolic Research Laboratories, Level 4, Institute of Metabolic Science, University of Cambridge, Addenbrooke’s Hospital, Box 289, Hills Road, Cambridge, CB2 0QQ, UK
- 3. INSERM Unit 780, Université Paris-Sud, Orsay, France
- 4. Division of Nephrology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
- 5. Department of Diabetes, School of Clinical Medical Sciences, University of Newcastle, Newcastle, UK
- 6. Department of Endocrinology, Odense University Hospital, Odense, Denmark
- 7. Metabolic Research Unit, St James’s Hospital & Trinity College Dublin, Dublin, Ireland